KRYS vs TECH · P/E 46, rev $290.5M vs P/E 65, rev $1.22B
Krystal Biotech Inc (KRYS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported KRYS revenue for 2024-12-31 was $290.5M. Net income was $89.2M. Revenue was up 473.0% from 2023-12-31 to 2024-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the KRYS and TECH stock pages for the full models.
Not investment advice.